NLX-112, a highly selective 5-HT1A receptor biased agonist, does not exhibit misuse potential in male rats or macaques
- 9 March 2022
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 210, 109025
Abstract
No abstract availableKeywords
Funding Information
- NIDA
This publication has 33 references indexed in Scilit:
- Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expressionJournal of Neural Transmission, 2011
- Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivationNature Protocols, 2007
- High-Efficacy 5-Hydroxytryptamine 1A Receptor Activation Counteracts Opioid Hyperallodynia and Affective ConditioningThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosetsPharmacology Biochemistry and Behavior, 2004
- Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in ratsBehavioural Pharmacology, 1997
- Modulation of the Discriminative Stimulus Properties of Cocaine: Comparison of the Effects of Fluoxetine with 5-HT1A and 5-HT1B Receptor AgonistsNeuropharmacology, 1997
- Addictive Drugs and Brain Stimulation RewardAnnual Review of Neuroscience, 1996
- Blockade of the discriminative stimulus effects of d-amphetamine in rhesus monkeys with serotonin 5-HT1A agonistsBehavioural Pharmacology, 1994
- 5-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation rewardJournal of Neural Transmission, 1991
- The Opioids:Advances in Alcohol & Substance Abuse, 1990